Bruker Daltonics Inc., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces novel biological agent detection arrays for its Assay Processing and Specific Identification System (APSIS(TM)). The increasing threat of biological terrorism drives the requirements for sophisticated bio-detection technologies to identify specific biological agents quickly and accurately. This is essential in order to minimize false alarms, to select appropriate countermeasures and containment strategies, if needed, and to minimize the overall health, psychological and economic damage
